What SENSIMED does

SENSIMED S.A. is a Swiss medical device company headquartered in Lausanne that designs, develops, and commercializes the SENSIMED Triggerfish®, a CE-marked and FDA-cleared smart contact lens system for continuous 24-hour ocular monitoring in glaucoma patients. The core product is a soft disposable silicone contact lens embedding a micro-sensor that captures spontaneous circumferential changes at the corneoscleral area, complemented by an adhesive antenna worn around the eye, a portable recorder, and Bluetooth-enabled software that transmits data to the physician's computer for analysis. This represents the first and only technology providing a complete 24-hour picture of ocular dimensional change, including sleep-period data that conventional in-clinic tonometry cannot capture.

The company's revenue model is hardware-based, selling the Triggerfish device and disposable lenses directly to ophthalmologists, glaucoma specialists, and eye care professionals, with a regional distribution partnership through SEED Co., Ltd. for the Japanese and broader Asian market. Sensimed sells through a sales-led motion targeting healthcare providers and reaches clinicians via participation in major ophthalmology conferences (AAO, ESCRS, ARVO, WGC, AGS, EGS), peer-reviewed publications (over 100 cited), and clinical whitepapers. Pricing is not publicly disclosed, and the clinical application requires two appointments (15–30 minutes each) for fitting and removal.

The company was founded in 2003 as a spin-off from EPFL and has accumulated regulatory milestones including CE mark (2010), FDA approval (2016), PMDA registration in Japan (2018), and ISO 13485 / MDSAP certifications. In November 2019, SEED Co., Ltd., a Japanese public contact lens company, acquired over 90% of Sensimed's outstanding shares, making Sensimed a majority-owned subsidiary operating within SEED's smart contact lens strategy. Sensimed employs between 11 and 50 staff and continues to focus on expanding clinical adoption of 24-hour ocular data profiles for personalized glaucoma management.

Name

SENSIMED

Legal name

Sensimed S.A.

Website

https://sensimed.ch

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

SENSIMED is a Swiss MedTech company that develops and commercializes the SENSIMED Triggerfish, a smart contact lens system providing 24-hour continuous ocular monitoring for glaucoma management, sold to ophthalmologists and eye care professionals globally.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851)

akta.pro primary industry

Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty) (HLAHAJAI)

akta.pro secondary industries

Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE), Visual Field & Functional Vision Testing (Perimetry, ERG/VEP, Contrast Sensitivity) (HLAHAJAC)

Keywords

• Smart contact lens
• Glaucoma monitoring devices
• Intraocular pressure monitoring
• Continuous ocular monitoring
• Medical device sensors

Headquarters

HQ city

Lausanne

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. SENSIMED Triggerfish Device Sales: The company generates revenue through the sale of its SENSIMED Triggerfish contact lens sensor system and disposable lenses, sold to healthcare facilities and ophthalmologists for clinical glaucoma management

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Sensimed designs, develops, and commercializes the SENSIMED Triggerfish, a CE-marked and FDA-approved continuous ocular monitoring system for clinical glaucoma management. The product is a soft disposable silicone contact lens with an embedded micro-sensor that captures spontaneous circumferential changes at the corneoscleral area, paired with an adhesive antenna, a portable recorder, and software that transfers data via Bluetooth for 24-hour continuous monitoring of ocular dimensional changes related to intraocular pressure.

Product overview

SENSIMED is a Swiss MedTech company offering a single unified product—the SENSIMED Triggerfish® continuous ocular monitoring system. This system comprises three integrated components working together: (1) a soft disposable silicone contact lens with an embedded micro-sensor, (2) an adhesive antenna that wirelessly receives information from the contact lens, and (3) a portable recorder that stores acquired data during the monitoring session, with data transferred via Bluetooth to practitioner software. The product is designed for 24-hour continuous monitoring of ocular dimensional changes to support glaucoma diagnosis and treatment decisions.

Differentiator

Problem solved

Functional benefit

Brands

• SENSIMED Triggerfish®: CE-marked and FDA-approved smart contact lens system for continuous 24-hour ocular monitoring in glaucoma patients. The device includes a disposable silicone contact lens with embedded microsensor, adhesive antenna, portable recorder, and associated software for data analysis.

Products and services

• SENSIMED Triggerfish® A CE-marked and FDA-approved continuous ocular monitoring system consisting of a soft disposable silicone contact lens with an embedded micro-sensor that captures spontaneous circumferential changes at the corneoscleral area, an adhesive antenna worn around the eye, a portable recorder, and Bluetooth-enabled software for physician analysis. Delivers 24-hour monitoring of ocular volume changes related to intraocular pressure for glaucoma specialists managing glaucoma diagnosis, treatment optimization, and identification of patients at risk for faster vision loss.

Quantifiable outcome

• 24-hour continuous ocular dimensional change recording including sleep periods
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• SEED Co., Ltd.coreStrategic or Co-development Partner · 1 January 2013SEED and Sensimed built a collaborative alliance since 2013 aimed at getting SENSIMED Triggerfish approved in Japan and capitalizing on the opportunity to spread the product throughout greater Asia.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Alcon: Alcon is a global eye care leader across surgical, vision care, and pharmaceuticals. Comparable as a contact lens/eye care giant with the resources to develop smart contact lens technology and disrupt Sensimed's niche.
• Nidek Co., Ltd. Nidek is a Japanese ophthalmic equipment manufacturer offering diagnostic, refractive, and surgical devices. Comparable as a broad incumbent serving the same ophthalmologist customer base, particularly relevant given Sensimed's Japanese ownership under SEED.
• Bausch + Lomb: Bausch + Lomb is a major contact lens and ophthalmic pharmaceutical manufacturer. Comparable as a contact lens manufacturer with ophthalmic franchise scale that could pursue smart contact lens opportunities similar to Sensimed's technology.
• Carl Zeiss Meditec: Carl Zeiss Meditec is a global leader in ophthalmic devices including diagnostic imaging, surgical microscopes, and IOLs. Comparable as a broad incumbent in ophthalmic diagnostics with the resources to bundle continuous monitoring into broader glaucoma workflows.
• Topcon Healthcare: Topcon is a major ophthalmic device manufacturer offering diagnostic imaging, refraction, and surgical equipment. Comparable as a broad incumbent serving ophthalmology practices with comprehensive diagnostic portfolios.

Emerging players

• Glaukos Corporation: Glaukos is a pioneer in MIGS (minimally invasive glaucoma surgery) devices and has expanded into comprehensive glaucoma management. Comparable as a focused glaucoma company addressing unmet needs in glaucoma care, though positioned in surgical rather than diagnostic space.
• Smartlens: Smartlens is an early-stage company developing smart contact lens technology for non-invasive health monitoring. Comparable as an emerging smart contact lens player with overlapping technological approach and potential future competition in continuous ocular monitoring.

Direct peers

• Reichert Technologies: Reichert is a long-established manufacturer of ophthalmic diagnostic instruments including tonometers and corneal measurement devices. Comparable to Sensimed as a specialist ophthalmic diagnostic instrument vendor serving eye care professionals.
• iCare (Revenio Group): iCare is a leading manufacturer of tonometers for intraocular pressure measurement, including rebound self-tonometry for home use. Directly comparable to Sensimed as both target the glaucoma diagnostic workflow, though iCare focuses on spot IOP measurements while Sensimed targets continuous monitoring.
• Heidelberg Engineering: Heidelberg Engineering specializes in ophthalmic diagnostic imaging (OCT, confocal laser imaging) widely used in glaucoma management. Comparable as a specialist diagnostic device vendor serving the same ophthalmology and glaucoma specialist customer base.

Market position

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sensimed-ag

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SENSIMED